Evolent Health Inc Class A (EVH) had a rough trading day for Monday November 11 as shares tumbled 8.4%, or a loss of $-0.85 per share, to close at $9.27. After opening the day at $10.10, shares of Evolent Health Inc Class A traded as high as $10.14 and as low as $9.08. Volume was 1.05 million shares over 8,051 trades, against an average daily volume of n/a shares and a total float of 84.52 million.
As a result of the decline, Evolent Health Inc Class A now has a market cap of $783.49 million. In the last year, shares of Evolent Health Inc Class A have traded between a range of $26.96 and $5.50, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company’s reportable segments are Service segment which includes value-based care services, specialty care management services and comprehensive health plan administration services. and True Health segment consists of a commercial health plan it operates in New Mexico that focuses on small and large businesses. It generates a majority of its revenue from the Service segment.
Evolent Health Inc Class A is based out of Arlington, VA and has some 3,800 employees. Its CEO is Frank J. Williams.
Evolent Health Inc Class A is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.